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Nutrition and Cancer. Vol. 6 in the series
on Current Concepts in Nutrition. M.
WINICK. (1977) Chichester: John Wiley &
Sons. 184 pp. £12.75 net.
It is becoming clear that nutritional status
can markedly influence the course of malig-
nant disease, but to date the precise mechan-
isms have not been clearly elucidated. This
book provides a comprehensive review of the
nutritional aspects of cancer that relate to
possible aetiology, dietary status, treatment
and prevention. Experimental evidence is
presented, showing the influence of various
dietary factors on the rate of growth and,
perhaps more important, on the aetiology of
certaintumours, notablybreastandcolon. The
problem of the cause and effect of malignant
cachexia is complex and, perhaps for this
reason, the section relating to biochemical
abnormalities is not covered as adequately as
are the subjects of the other 2 sections. The
final section discusses the various methods
of improving nutritional status with dietary
supplements, and this should particularly
appeal to all those concerned in managing
patients with malignant disease. The book
should appeal to both relevant nursing and
medical staff, and also to research workers
concerned with this particular aspect of
cancer.
P. M. WILKINSON
Antibiotics and Chemotherapy. 24. Appli-
cation of Cancer Chemotherapy. Ed.
SCHABEL JR. (1978) London: S. Karger.
242 pp. US $37.00.
This book contains a series of collected
papers that were presented at the 10th
International Congress of Chemotherapy in
Zurich in 1977. The first section contains some
experimental studies relating to immuno-
therapy, but unfortunately because of the
complexity of this particular subject the
information presented will be of value only
to a specialist in this field. The next 2
sections relate toadjuvantchemotherapy and
chemotherapy particularly ofthe lymphomas.
In general, each is a short presentation
describing collective series of work that have
now been published in more detail elsewhere.
A review of gastro-intestinal cancer follows
and this illustrates well the practical diffi-
culties associated with the chemotherapy of
this disease. The final section deals with the
treatment of breast cancer, and here the
standard of presentation of the articles is
considerably better than in the previous
sections.
With the exception of the last section, the
majority of the articles have since been
published in reputable journals that are
presumably read by people involved in the
treatment of cancer, and it is therefore diffi-
cult to justify the purchase ofthis volume by
an individual. It would, however, be of
value as a reference work in appropriate
libraries.
P. M. WILKINSON
Progress in Cancer Research and Ther-
apy, Vol. 6. Immunotherapy of Cancer:
Present Status of Trials in Man.
Eds W. D. TERRY AND D. WINDHORST
(1978) New York: Raven Press. 726 pp.
US$ 64.35.
Fifty years ago, Woglom wrote a review
which, with precise aim and a razor-sharp
wit, severed the jugular vein of tumour
immunology. The wound was not fatal but
the subject was anaemic for a very long
time. The much needed transfusion, the
unequivocal demonstration of tumour-
specific transplantation antigens in some
animal tumours, occurred in the 1950s and
the topic has been thriving ever since, as
much in the clinic as in the laboratory. This
book, number 6 in an excellent series, is a
comprehensive, detailed and timely appraisal
of what clinical cancer immunotherapy has
achieved so far, and it spills quite a lot of
blood. It is all there. In nearly 700 pages the
world's clinical experience (since the 1950s) is
described by most ofthe world's experts. The
editor has provided the ideal forum forBOOK REVIEWS 103
them and for a long hard look at the claims
thev make for this fashionable mode of treat-
ment.
Each section starts with a chapter on the
natural historv and conventional manage-
ment ofeach disease to be discussed. Divided
into 6 such sections. it deals in turn with
malignant melanoma, lung cancer. osteogenic
sarcoma. the acute leukaemias. gastrointes-
tinal tumours and finallv carcinoma of the
breast. This was a particularly bright idea
since these chapters are excellent reviews
and the detailed descriptions of the results of
immunotherapy which follow are seen in
perspective, and in many cases not seen to
advantage.
Published symposia are frequentlv marred
bv verbatim transcripts of discussions which
rarelv convev much except the egos of the
participants. This book is verv different. The
discussions are, in many wavs. its most
important and informative feature. The
questions are aggressive. the answers reveal-
ing. Mfany contributors received a grilling
which would not have disgraced the Spanish
Inquisition. Few presenters escaped un-
scathed from this critical scrutinv. The
tenor of the general discussions conveys an
earnest and objective determination to get
at the facts. For example, in the discussion
following the session on gastrointestinal
cancer. Dr Moertel made a perceptive remark
which induced some ofthe liveliest exchanges
to be seen on a printed page. Bv pointing out
that all prospective randomized immuno-
therapy trials give negative results, whereas
the use ofhistorical controlsalmostguarantees
'positive' data. he sparked off an explosive
interchange among the interested parties
which. now it is in black and white. must at
last put a wooden stake through the heart of
the historically controlled trial.
Mr Richard Peto made another telling
point in discussion. There are now so many
clinical immunotherapy trials. he said, that
the published claims for clinical benefit
constitute what one would expect by chance
alone if the treatment were valueless. The
session chairman was clearly upset by this
remark. accused him of unfairness and
defended the trials presented as pointers to
the future. directions to follow. This comment
led your intrepid reviewer on vet another
(and enjoyable) expedition through the dense
undergrowth of this lush volume on a singu-
larlv unsuccessful hunt for such pointers.
Dr Terrv. whose spectacles are of a rosier
hue. undertook a similar task in his con-
cluding remarks. Did he fare any better?
Asking the question where do we go from
here?" (and disregarding the possible answer
that here may not be the best place to start)
he concludes that clinical immunotherapy is
here to stay and the future is reasonably
(sit) bright. Of clues, however. he finds but
few. Sensibly he recognizes. and indeed em-
phasizes. the need to understand more about
immunity before we fiddle with it. There
needs (although he does not quite say so) to
be a radical reappraisal of directions, a
retreat to base camp to plan new directions
from that ivorv tower of the modern medical
world. the immunology laboratory.
Cancer immunotherapy was, and still is
a good idea and this excellent volume is an
important landmark in the evolution of that
idea. It should be compulsory reading for
anvone entertaining immunological ideas
about cancer.
G. A. CITRRIE
Integration and Excision of DNA
Molecules. Eds. P. H. HOFSCHNEIDER &
P. STARLNGER. (1978) Berlin: Springer
Verlag. 134 pp. $24.00 net.
This interesting little book will be wel-
comed by cell biologists. biochemists. and
cancer workers wishing to keep in touch with
recent developments in DNA recombination
research. It consists of 18 mini-reviews con-
cerning the mechanism and biological signi-
ficance of DNA recombination and integra-
tion which were presented at a Colloquium at
Mosbach. April 1977. As with all proceedings
of meetings, the information presented
reflects the views of the authors and there is
no space in a book of this size for conflicting
arguments. Rather the organizers have
brought together a group of leading authori-
ties to summarize the most exciting facets of
recombination research in different biological
systems.
The biochemistry of recombination is
described for E. coli phages T4 (3Mosig) and
A (Nash) and the control of A integration by
Ptashne. The mutational properties and
genetic structure of phage MIu (van de Putte)
and the transposable elements, transposons